Work

Phase II study of bevacizumab and vorinostat for recurrent glioblastoma.

Year: 2015

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2015.33.15_suppl.2034

Authors: Ashley Ghiaseddin, David A. Reardon, Woody Massey, Alexandra Mannerino, Eric S. Lipp, James E. Herndon, Frances McSherry, Annick Desjardins, Dina M Randazzo, Gordana Vlahovic, Henry S. Friedman, Katherine B Peters

Institutions: Duke Medical Center, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2597126480

Cites:

Cited by: 6

Related to: 10